Home > Healthcare > Medical Devices > Medical Supplies > Biochemical Reagents Market
Biochemical reagents market size was valued at around USD 24.3 billion in 2023 and is estimated to grow at 8.5% CAGR from 2024 to 2032. Biochemical reagents are substances utilized in biochemical experiments and analyses to facilitate the detection, measurement, or manipulation of specific biochemical components or processes. These reagents often interact with biological molecules such as proteins, nucleic acids, carbohydrates, and lipids, enabling researchers to study their properties, functions, and interactions within living organisms.
The increasing R&D activities in life sciences and biotechnology is a significant driving factors for the market. For instance, in 2021, Hangzhou Sciwind Biosciences Co. Ltd. (Sciwind), a rapidly advancing clinical-stage biopharmaceutical firm, secured USD 37 million in Series B funding from LYFE Capital. This investment aims to expedite the research and development of groundbreaking biologics targeting chronic metabolic and immunological disorders.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Biochemical Reagents Market Size in 2023: | USD 24.3 Billion |
Forecast Period: | 2024 - 2032 |
Forecast Period 2024 - 2032 CAGR: | 8.5% |
2032 Value Projection: | USD 50.4 Billion |
Historical Data for: | 2021 - 2023 |
No. of Pages: | 170 |
Tables, Charts & Figures: | 229 |
Segments covered: | Product Type, Application, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Furthermore, rising incidence of chronic and infectious diseases, expanding of the biopharmaceutical industry, increasing drug discovery services (market size is estimated to account for USD 61.6 billion by the end of year 2032), advancements in drug screening market, government initiatives and funding, and increasing education & awareness, are the promoting factors fostering the growth of the market.